FFA
AMGN icon

Fairfield Financial Advisors’s Amgen AMGN Stock Holding History

Fairfield Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Sell
5,171
-164
-3% -$58.5K 0.63% 33
2025
Q4 		$1.75M Sell
5,335
-530
-9% -$168K 0.57% 35
2025
Q3 		$1.66M Sell
5,865
-1,584
-21% -$459K 0.56% 37
2025
Q2 		$2.08M Sell
7,449
-39
-0.5% -$11K 0.73% 33
2025
Q1 		$2.33M Sell
7,488
-568
-7% -$168K 0.88% 27
2024
Q4 		$2.1M Sell
8,056
-228
-3% -$67.6K 0.74% 24
2024
Q3 		$2.67M Buy
8,284
+193
+2% +$63.1K 0.91% 22
2024
Q2 		$2.53M Buy
+8,091
New +$2.38M 0.74% 24
2023
Q4 		$2.1M Buy
7,294
+303
+4% +$82.6K 0.8% 28
2023
Q3 		$1.88M Buy
6,991
+644
+10% +$161K 0.79% 28
2023
Q2 		$1.41M Buy
6,347
+1,498
+31% +$348K 0.56% 33
2023
Q1 		$1.17M Buy
4,849
+619
+15% +$152K 0.51% 32
2022
Q4 		$1.11M Buy
4,230
+388
+10% +$104K 0.51% 31
2022
Q3 		$866K Buy
3,842
+469
+14% +$114K 0.41% 33
2022
Q2 		$821K Sell
3,373
-113
-3% -$27.7K 0.38% 35
2022
Q1 		$843K Buy
+3,486
New +$801K 0.3% 38

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fairfield Financial Advisors's AMGN Position: Q1 2026 in Review

Fairfield Financial Advisors reduced its Amgen (AMGN) stake by 3.1% in Q1 2026, selling an estimated $58.5K and leaving 5,171 shares worth $1.82M. The position accounts for 0.63% of the portfolio, ranked #33.

Fairfield Financial Advisors first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.67M in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Fairfield Financial Advisors held 5,171 shares of Amgen worth $1.82M as of Q1 2026.
  • Fairfield Financial Advisors sold 164 Amgen shares in Q1 2026, an estimated $58.5K.
  • Amgen made up 0.63% of Fairfield Financial Advisors's portfolio in Q1 2026, its #33 holding.
  • Fairfield Financial Advisors first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
  • Fairfield Financial Advisors's Amgen position peaked at $2.67M in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Fairfield Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.